TNBC-DX Genomic Test for Early-Stage TNBC Treated With Neoadjuvant Taxane-Based Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy
Ann. Oncol 2024 Oct 15;[EPub Ahead of Print], M Martín, SR Stecklein, O Gluz, G Villacampa, M Monte-Millán, U Nitz, S Cobo, M Christgen, F Brasó-Maristany, EL Álvarez, I Echavarría, B Conte, S Kuemmel, C Bueno-Muiño, Y Jerez, R Kates, M Cebollero, C Kolberg-Liedtke, O Bueno, JÁ García-Saenz, F Moreno, EM Grischke, H Forstbauer, M Braun, M Warm, J Hackmann, C Uleer, B Aktas, C Schumacher, R Wuerstleins, M Graeser, C Eulenburg, HH Kreipe, H Gómez, T Massarrah, B Herrero, L Paré, U Bohn, S López-Tarruella, A Vivancos, E Sanfeliu, JS Parker, CM Perou, P Villagrasa, A Prat, P Sharma, N HarbeckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.